baber/WOPTO huggingface dataset:
Patent AU-586642-B2 (AU)
Title: An isolating device
Inventor: DOLANSKY FRANZ
IPC: H04Q1/14
Filed: 1985-09-27
Granted: 1989-07-20
Abstract: In the cut-over device, the two cut-over contacts formed by the contact springs (5) connected to the connecting terminals (4) are arranged to be offset for each pair of wires. In addition, the associated openings (6) located above in the housing (1) of insulating material of the cut-over device have different sizes. This prevents accidental cross connection between two wire pairs.
Patent AU-738429-B2 (AU)
Title: Method and device in telecommunications network
Inventor: HULTGREN ANDERS
IPC: H04M3/42
Filed: 1997-12-18
Granted: 2001-09-20
Abstract: The present invention concerns a method and an apparatus for designing, providing and managing customer services in a telecommunications network. The services are handled in a separate service network, connected to the telecommunications network in a logical service means, for example an SCP in an intelligent network. The service network is based on existing and commonly available network resources, for example, the Internet. Also, existing and commonly available terminals, such as personal computers are used for handling the services.
Patent AU-615134-B2 (AU)
Title: Low calorie fat substitute
Inventor: HENDRICK MICHAEL E
IPC: A23L1/00
Filed: 1990-01-24
Granted: 1991-09-19
Abstract: There is disclosed a low calorie fat substitute comprising an outer coating of a digestible fat surrounding an inner core of a low caloric or non-caloric material.
Patent AU-583545-B2 (AU)
Title: Improvements in or relating to lavatory units
Inventor: BLANCHARD CLAUDE GEORGES ANDRE
IPC: A47K13/30
Filed: 1985-10-21
Granted: 1989-05-04
Abstract: Sanitary installation. The lavatory seat comprises: a bowl comprising on its upper rim, support and guiding means which are interrupted, a seat formed by a closed ring mounted on said means, a unit for cleaning the peripheral surface of the seat, a driving member for driving the seat in a sliding movement on the means, and means for controlling: the operation of the unit, and the supply of the motor conjugated to the operation of the unit, Application to lavatory seats with incorporated flush tank.
Patent AU-630661-B2 (AU)
Title: Derivatives of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and their pharmacological properties
Inventor: POLI STEFANO
IPC: A61P43/00
Filed: 1990-02-09
Granted: 1992-11-05
Abstract: Ester or amide derivatives of 3-pyroglutamyl-thiazolidine-4-carboxylic acid exhibit interesting immunostimulating, antitoxic, antiinflammatory, antioxidental, antiageing properties.
Patent AU-596084-B2 (AU)
Title: Method of obtaining cellulase deficient strains of white-rot fungi
Inventor: ERIKSSON KARL-ERIK
IPC: A23K10/32
Filed: 1985-09-18
Granted: 1990-04-26
Abstract: PCT No. PCT/SE85/00358 Sec. 371 Date May 16, 1986 Sec. 102(e) Date May 16, 1986 PCT Filed Sep. 18, 1985 PCT Pub. No. WO86/01843 PCT Pub. Date Mar. 27, 1986.A method is described of obtaining cellulase deficient strains which have great ability to degrade lignin at the same time. The method comprises crossing a homokaryotic cellulase deficient mutant of a white-rot fungus having a full sexual cycle with a homokaryotic strain of the same fungus, this strain having great lignin degrading ability. Strains are subsequently selected that have great lignin degrading ability in combination with cellulase deficiency. A suitable white-rot fungis is Phanerochaete chrysosporium. The crossings are suitably performed for a plurality of generations. The strain of white-rot fungus obtained is used for delignifying lignocellulosic material.
Patent AU-620504-B2 (AU)
Title: Improvements relating to injection molding machines
Inventor: DISIMONE JOHN
IPC: B29C45/12
Filed: 1990-03-30
Granted: 1992-02-20
Abstract: The present invention relates to a device for removing workpieces from a wide variety of injection molding machines, particularly stack mold machines. The device includes at least one suction cup (24) for grasping and rotating each workpiece through an approximate 90 DEG arc from a position intermediate the mold portions to a position outboard of the mold portions. The suction cup(s) (24) are mounted to a rotatable shaft (28) which is actuated by a cam-operated linkage assembly (32, 34, 36).
Patent AU-775122-B2 (AU)
Title: Improved process for manufacture of polyvinyl chloride
Inventor: BONARDI CHRISTIAN
IPC: C08F2/38
Filed: 2001-07-25
Granted: 2004-07-15
Abstract: In the process according to the invention for the aqueous suspension polymerization of vinyl chloride, alone or as a mixture with another vinyl monomer, the polymerization initiator comprises at least one compound chosen from dialkyl peroxydicarbonates, peroxy-tert-alkanoates and diacyl peroxides and use is made, as agent for halting the polymerization, of a mono- or disubstituted hydroxylamine. The resins thus obtained exhibit improved color and heat stability.
Patent AU-777522-B2 (AU)
Title: Chromeno(4,3,2-de)isoquinolines as potent dopamine receptor ligands
Inventor: NICHOLS DAVID E
IPC: A61K31/4741
Filed: 2000-06-20
Granted: 2004-10-21
Abstract: Novel dopamine receptor ligands of the formula: pharmaceutical formulations of such compounds, and a method using such compounds for treating a patient suffering from dopamine-related dysfunction of the central or peripheral nervous system, are described. The compounds are expected to be useful in treating Parkinson's disease, improving cognition, improving memory, improving the negative symptoms of schizophrenia, improving attention-deficit hyperactivity disorder and related developmental disorders, treating substance abuse disorders, and in treating various peripheral conditions where changes in dopamine receptor occupation affects physiological function, including organ perfusion, cardiovascular function, and selected endocrine and immune system functions.
Patent AU-725778-B2 (AU)
Title: Snooker table
Inventor: HEGGIE DAVID WATSON MCINTYRE
IPC: A63D15/00
Filed: 1998-02-05
Granted: 2000-10-19
Abstract: The present invention relates to a snooker table (10) having a conventional rectangular outer frame opposed major sides (12, 14) and minor sides (16, 18). The playing surface (20) is non-rectangular, in that a pair of arrowhead or "V' shaped projections (22, 24) extend inwardly from respective major sides (12, 14). The playing surface (20) thus has an hour glass-type shape, and is bounded by a conventional cushion (26). Pockets are provided at opposite corners of the table, as in conventional snooker table. The projections (22, 24) terminate in similar pockets (30A, 30B), which are located along the same center line as the middle pockets of a standard snooker table, but which are spaced inwardly relative thereto. The snooker table provides for a snooker type game which is both versatile and challenging.
Patent AU-729548-B2 (AU)
Title: Process for the preparation of substituted anthraquinones and application to the preparation of rheins
Inventor: ESTANOVE CYRIL
IPC: C07C/
Filed: 1998-02-02
Granted: 2001-02-01
Abstract: PCT No. PCT/FR98/00189 Sec. 371 Date Oct. 2, 1998 Sec. 102(e) Date Oct. 2, 1998 PCT Filed Feb. 2, 1998 PCT Pub. No. WO98/33757 PCT Pub. Date Aug. 6, 1998The invention relates to a process for the preparation of substituted anthraquinones represented by the general formula (I): by Diels-Alder reaction between a 1,4-naphthoquinone of general formula (II): and an acyclic diene of formula (III): CH2=CR-CH=CH-OR3(III) followed by an oxidizing deprotection reaction by means of the Jones reagent, in order to obtain the substituted anthraquinone of general formula (I). Application to the preparation of rheins of use in pharmaceuticals.
Patent AU-719446-B2 (AU)
Title: Vectors for the diagnosis and treatment of solid tumors including melanoma
Inventor: PAWELEK JOHN M
IPC: A61K48/00
Filed: 1996-06-05
Granted: 2000-05-11
Abstract: The present invention is directed to the isolation and use of super-infective, tumor-specific vectors that are strains of parasites including, but not limited to bacteria, fungi and protists. In certain embodiments the parasites include, but are not limited to, the bacterium Salmonella spp., such as Salmonella typhimurium, the bacterium Mycobacterium avium and the protozoan Leishmania amazonensis. In other embodiments, the present invention is concerned with the isolation of super-infective, tumor-specific, suicide gene-containing strains of parasites for use in treatment of solid tumors.
Patent AU-701697-B2 (AU)
Title: Aqueous compositions containing ciprofloxacine, and related use and process
Inventor: SOLER PEDRO CANOVAS
IPC: A61K47/12
Filed: 1996-07-26
Granted: 1999-02-04
Abstract: Aqueous compositions containing ciprofloxacine, and corresponding use and process, said composition comprising from 0.12 to 0.6 g/100 ml of chlorohydrate monohydrate of ciprofloxacine (equivalent to 0.1-0.5 % of free base); from 0.5 to 3.0 g/100 ml of a buffer system capable of maintaining the pH between 4 and 5; from 0.05 to 0.3 g/100 ml of a non-ionic surface-active agent; from 0.5 to 2.0 g/100 ml of a thickening agent, and the rest to 100 ml of water.
Patent AU-582288-B2 (AU)
Title: Vector and method for achieving high level expression in eukaryotic cells
Inventor: GILLIES STEPHEN D
IPC: C12N15/67
Filed: 1986-11-25
Granted: 1989-03-16
Abstract: A DNA construct for fabricating a vector for transfecting a cell to achieve high level expression of a gene within the vector encoding a protein prod. comprises (a) DNA defining an enhancer element operative to enhance promotion of transcription of genes located in regions on both the 5' and 3' sides, (b) DNA defining a transcriptionally competent marker region comprising a promoter and a gene encoding a selectable marker, located in a region on one side of the enhancer element, (c) DNA oefining a restriction site, disposed adjacent the 3' end of a promoter, for ligating a gene encoding a protein prod., located in a region on the other side of the enhancer element at a distance to permit enhancement of expression of the gene encoding a protein prod. and (d) DNA defining a blocking element, interposed between the enhancer element and the marker region, operable to block enhancement of transcription of the gene encoding a selectable marker by the enhancer element.
Patent AU-688323-B2 (AU)
Title: New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
Inventor: MAERTENS GEERT
IPC: C12Q1/68
Filed: 1994-04-27
Granted: 1998-03-12
Abstract: The present invention relates to new polynucleic acid and amino acid sequences corresponding to new HCV type 5 sequences. The present invention also relates to the use of these polynucleic acids and amino acids in methods or processes for the detection of one or more HCV genotypes, or for the preparation of antibodies against new HCV type 5 polypeptides. The invention also includes compositions comprising said polynucleic acid and amino acid sequences. The present invention further relates to kits comprising polynucleic acid probes and/or primers defined by the invention, or comprising polypeptides according to the invention.
Patent AU-783745-B2 (AU)
Title: Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
Inventor: AGRAWAL SUDHIR
IPC: C12N15/09
Filed: 2000-08-14
Granted: 2005-12-01
Abstract: The invention provides methods for modulating the immune response caused by CpG-containing oligonucleotides. The methods according to the invention enable decreasing the immunostimulatory effect for antisense applications.
Patent AU-610059-B2 (AU)
Title: Method of producing a recombinant protein complex having human factor VIII:C activity
Inventor: BURKE RAE LYN
IPC: A61K35/16
Filed: 1987-01-27
Granted: 1991-05-16
Abstract: Compositions having Factor VIII:C activity and immunologically cross-reactive with Factor VIII:C are prepared by the expression of genes encoding for the N-terminus and C-terminus of the Factor VIII:C gene, whereby each of those sequences has an independent signal sequence. The structural genes for the N- and C-termini may be on the same or different DNA constructs, each having independent transcriptional and translational regulatory signals. The construct(s) is/are introduced into mammalian cells whereby an active protein complex is produced having Factor VIII:C activity.
Patent AU-637661-B2 (AU)
Title: Conformable absorbent article
IPC: A61F13/56
Filed: 1990-12-18
Granted: 1993-06-03
Abstract: A conformable absorbent article (10) has a topsheet (26) that is designed to substantially fully contact the body of the wearer to provide improved performance in managing and containing body wastes. Management and containment of body wastes are improved by several structural elements that can be utilized individually or collectively. Some of these elements are a waste-containment pocket (56) formed between the topsheet (26) and backsheet (30), an opening (38) in the topsheet (26) for receiving body wastes therethrough, a pair of containment flaps (50) and a pair of side flaps (60), and an expandable backsheet (30) to retain body wastes therein. <IMAGE>
Patent AU-545187-B2 (AU)
Title: Cultivation of cocoa cotyledons
Inventor: JANICK JULES
IPC: A01G7/00
Filed: 1981-03-20
Granted: 1985-07-04
Abstract: A method of producing mature cacao embryos involves culturing zygotic embryos in a basal medium with auxin and sugar to initiate asexual embryos, proliferating the embryos in the medium with low sugar content, and increasing the size and maturity of the embryos without germination and with increased sugar content in the medium.
Patent AU-650857-B2 (AU)
Title: Antibody variable domain conjugates
Inventor: DAVIS PAUL JAMES
IPC: G01N33/532
Filed: 1990-11-27
Granted: 1994-07-07
Abstract: Small specific binding molecules, such as single variable domain antibodies (Dabs) and Fv fragments, can be coupled to solid plastics surfaces or to tracers such as enzymes by means of linkers comprising polypeptides containing from 5 to 20 amino acids and which are hydrophobic and/or contain at least one lysine residue. The coupling can be achieved without significant loss of specific binding activity. The combined Dab/linker or Fv/linker can be prepared by expression in genetically-modified organisms.
Patent AU-710494-B2 (AU)
Title: Plasmid stabilization
Inventor: SHERRATT DAVID JOHN
IPC: C12N15/64
Filed: 1996-09-06
Granted: 1999-09-23
Abstract: A system is described which utilizes a novel system of repressor titration for maintenance of a plasmid useful in gene therapy and production of a recombinant protein. The system utilizes a transformed host cell containing a plasmid including an operator susceptible to binding by a repressor expressed in trans, a first chromosomal gene encoding the repressor, and a second chromosomal gene that is functionally associated with an operator and essential for cell growth, wherein the plasmid is present in the cell in sufficient numbers to titrate the repressor such that the essential gene is expressed, thereby permitting cell growth.
Patent AU-655759-B2 (AU)
Title: Method of making factor-dependent human B cell lines
Inventor: BANCHEREAU JACQUES
IPC: C12N5/10
Filed: 1990-12-13
Granted: 1995-01-12
Abstract: A method is provided for establishing factor dependent human B cell lines capable of secreting immunoglobulin of a desired specificity and capable of long term culturing. The method includes selecting a resting B cell having immunogiobulin of the desired specificity and culturing it in the presence of an agent capable of cross-linking its CD40 surface antigens. Long term culture requires the continued presence of the cross-linking agent. Preferably, the cross-linking agent is a monoclonal antibody specific for the CD40 antigen, presented by non-replicating mammalian cells expressing Fc gamma -RII.
Patent AU-682702-B2 (AU)
Title: Process for the preparation of phenylalanine derivatives or homologues containing a guanidino or modified guanidino group useful for the preparation GnRH of antagonistic peptides
Inventor: HOEGER CARL A
IPC: C07C277/08
Filed: 1994-06-13
Granted: 1997-10-16
Abstract: Methods of making unnatural amino acids are provided which unnatural amino acids can be incorporated into peptides which either inhibit or promote the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. These unnatural amino acids are useful in the synthesis of peptides and have the formula (a):   <IMAGE>   where W is (CH2)n or   <IMAGE>   n is an integer from 1 to 6; j=1, 2 or 3, and preferably, Y is N-CN, X is NH and R2 is alkyl, modified alkyl, alkenyl, alkynyl, aryl or methyl pyridyl. Disclosed are peptides that are analogs of the decapeptide GnRH wherein there is at least one residue of an unnatural amino acid in the 3-, 5-, 6- and/or 8-positions.
Patent AU-634350-B2 (AU)
Title: New derivatives having naphthalene structure, process for preparing these and pharmaceutical compositions containing them
IPC: C07C233/17
Filed: 1991-02-26
Granted: 1993-02-18
Abstract: Compounds of the formula:   <IMAGE>   in which: A represents   <IMAGE>   R represents linear or branched lower alkyl, R1 represents hydrogen or linear or branched lower alkyl, and R2 represents aryl or lower arylalkyl or aryl or lower arylalkyl substituted by lower alkyl, lower alkoxy, trifluoromethyl, or halogen, aryl means phenyl or naphthyl, as well as optical isomers, epimers and diastereoisomers and addition salts thereof with a pharmaceutically-acceptable acid, lower alkyl and lower alkoxy having 1 to 6 carbon atoms inclusive, and medicaments containing the same which are useful for the treatment of disorders of the melatoninergic system.
Patent AU-676596-B2 (AU)
Title: Insert for carbonated beverage container
Inventor: WRIGHT TIMOTHY
IPC: B65D25/02
Filed: 1994-08-11
Granted: 1997-03-13
Abstract: PCT No. PCT/GB94/01755 Sec. 371 Date Jan. 30, 1996 Sec. 102(e) Date Jan. 30, 1996 PCT Filed Aug. 11, 1994 PCT Pub. No. WO95/05325 PCT Pub. Date Feb. 23, 1995A carbonated beverage container (10, 35, 40) including a hollow insert (1, 20) which floats in the beverage (11). the insert (1, 20) has two one-way valves (6, 7, 28, 29), one (6, 28) of which allows gas from a headspace above the beverage (11) to enter the insert (1, 20), the other (7, 29) allowing gas from the insert (1, 20) to be jetted into the beverage (11) upon opening the container (10, 35, 40). This jet of gas into the beverage (11) causes shear, and the liberation of gas bubbles which form a close-knit creamy head on the beverage (11) once dispensed.
Patent AU-639770-B2 (AU)
Title: Oligonucleotide analogs
IPC: C07H19/06
Filed: 1991-02-25
Granted: 1993-08-05
Abstract: Oligonucleotides possessing at least one sulfamate or sulfamide internucleotides linkages. These compounds can be used as specific hybridization probes to detect complementary nucleic acid sequences.
Patent AU-678854-B2 (AU)
Title: Sewage treatment apparatus and method
Inventor: FASSBENDER ALEX G
IPC: C02F1/02
Filed: 1994-09-02
Granted: 1997-06-12
Abstract: The invention greatly reduces the amount of ammonia in sewage plant effluent. The process of the invention has three main steps. The first step is dewatering without first digesting, thereby producing a first ammonia-containing stream having a low concentration of ammonia, and a second solids-containing stream. The second step is sending the second solids-containing stream through a means for separating the solids from the liquid and producing an aqueous stream containing a high concentration of ammonia. The third step is removal of ammonia from the aqueous stream using a hydrothermal process.
Patent AU-681716-B2 (AU)
Title: Stabilisation of polyunsaturates
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K36/67
Filed: 1994-10-18
Granted: 1997-09-04
Abstract: PCT No. PCT/GB94/02277 Sec. 371 Date Oct. 16, 1996 Sec. 102(e) Date Oct. 16, 1996 PCT Filed Oct. 18, 1994 PCT Pub. No. WO95/11289 PCT Pub. Date Apr. 27, 1995Polyunsaturated oils such as triply or higher ethylenically unsaturated organic materials are stabilized against ambient temperature atmospheric oxidation by the addition of an essential oil such as thyme oil, oregano oil, pepper oil or clove oil.
Patent AU-558931-B2 (AU)
Title: A process and apparatus for the recovery of immunoglobulins
Inventor: GANI M M MAY K PORTER P
IPC: B01J20/32
Filed: 1982-02-24
Granted: 1987-02-12
Abstract: PCT No. PCT/GB82/00060 Sec. 371 Date Sep. 22, 1982 Sec. 102(e) Date Sep. 22, 1982 PCT Filed Feb. 24, 1982 PCT Pub. No. WO82/02818 PCT Pub. Date Sep. 2, 1982.A process for the recovery of immunoglobulins of high purity and potency from milk, in which process milk is passed through a re-usable immunoadsorbent column comprising an insoluble carrier material to which is bound a low-affinity monoclonal antibody specific to one or more milk immunoglobulins but not specific to any other common constituent of milk, the antibody bind immunoglobulin molecules are released by eluting the immunoadsorbent.
Patent AU-756962-B2 (AU)
Title: The HA-1 antigen
Inventor: GOULMY ELSA AFRA JULIA MARIA
IPC: C12N5/09
Filed: 1998-07-23
Granted: 2003-01-30
Abstract: Peptide sequences constituting T-cell epitopes of minor Histocompatibility antigen, HA-1. HA-1 is associated with Graft versus Host Disease. The peptides and their derivatives find many uses, for instance, in bone marrow transplantation, organ transplantation and in treatment of leukemia and non-hematopoietic tumors. The peptide and/or its derivatives can be incorporated in vaccines, in pharmaceutical formulations and they can be used in diagnostic test kits. HA-1 is expressed by non-hematopoietic tumor cells. While absent in normal epithelial cells, tumor cells and tumor cell lines, particularly from epithelial origin, express HA-1 and are recognized by HA-1 cytotoxic T-cells. The invention provides means and methods for HA-1 specific immunotherapy for HA-1-positive patients with non-hematopoietic tumor cells.
Patent AU-666108-B2 (AU)
Title: CDT mutants of salmonella typhi
Inventor: CURTISS ROY III
IPC: C12N15/00
Filed: 1991-11-08
Granted: 1996-02-01
Abstract: This invention provides immunogenic compositions for the immunization of a vertebrate or invertebrate comprising an avirulent derivative of S. typhi. The derivatives having a mutation of the cya and/or crp and/or cdt genes. The invention also provides immunogenic compositions for the immunization of a vertebrate and invertebrate comprising an avirulent derivative of the above type which is capable of expressing a recombinant gene derived from a pathogen of said vertebrate or invertebrate individual to produce an antigen capable of inducing an immune response against said pathogen. Other embodiments of the invention include methods of preparing immunogenic compositions from these strains, and strains useful in the preparation of the immunogenic compositions, as well as methods of stimulating the immune system to respond to an immunogenic antigen of S. typhi by administration of the immunogenic composition.
Patent BG-52079-B2 (BG)
Title: Spectrodividing photometric head for a device for the identification of chromatic targets
Inventor: GRITSKOV ALEKSANDR M
IPC: G01N21/00
Filed: 1987-12-28
Abstract: The spectrodividing photometric head is used in devices for the automation of agrotechnical technological processes. It is more stable in respect of climatic and soil conditions and is more selective. It consists of an optical part made of multilayer interference filters and dichroic elements dividing the luminous flux into two or more channels in the range from 610 to 720 nm 10 and from 720 to 800 nm     10 in case of two channels. The photoreceivers are silicon diodes operating at close velocities of photogeneration and electrical modes.
Patent CY-2583-B2 (CY)
Title: Reshaped monoclonal antibodies against an immunoglobulin isotype
Inventor: HARDMAN NORMAN
IPC: C07K16/00
Filed: 2005-09-08
Abstract: The invention relates to reshaped human monoclonal antibodies directed against isotypic determinants of immunoglobulin E (IgE), direct equivalents and derivatives of said antibodies. The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.